Loading...

Medical-Grade Silicone Launch and Production Cuts Will Balance Future Prospects

Published
09 Feb 25
Updated
27 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
51.3%
7D
6.0%

Author's Valuation

NOK 29.86.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 27 Nov 25

ELK: New Medical-Grade Product Launch and Market Risks Will Shape Outlook

Analysts have maintained Elkem's fair value price target at NOK 29.80, citing stable underlying financial metrics and a slightly reduced discount rate as the basis for their decision.

What's in the News

  • Elkem ASA launched SILBIONE LSR Select EC 70, a next-generation medical-grade liquid silicone rubber designed for wearable and diagnostic devices. The material offers high electrical conductivity, certified biocompatibility, and improved process control for precision healthcare applications (Key Developments).
  • SILBIONE LSR Select EC 70 features resistivity below 10 ohm-centimeters. This makes it suitable for use in flexible electronics, advanced sensors, and prosthetics. It has passed ISO 10993-5 and ISO 10993-10 safety tests, confirming its suitability for medical applications (Key Developments).
  • Elkem ASA announced a partial curtailment of ferrosilicon production at its plants in Rana, Norway, and Iceland due to weak market demand in Europe and increasing uncertainty related to an EU investigation into potential import safeguard measures (Key Developments).
  • The curtailment may lead to temporary employee layoffs and is intended to help reduce inventories and support improved market balance in the steel industry (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target remains unchanged at NOK 29.80.
  • Discount Rate has decreased modestly from 8.02% to 7.94%.
  • Revenue Growth projection is steady at 36.49%.
  • Net Profit Margin is largely unchanged and remains at approximately 6.05%.
  • Future P/E ratio has edged down slightly from 9.16x to 9.14x.

Key Takeaways

  • Strategic review and operational improvements, especially in China, may enhance competitiveness and increase earnings upon completion by year-end.
  • Diverse geographical presence and R&D initiatives in sustainability could drive revenue growth and strong net margins amid global trade tensions.
  • Global trade tensions, weak market demand, and strategic uncertainties threaten Elkem's revenues, margins, and market stability across key sectors.

Catalysts

About Elkem
    Engages in the provision of advanced material solutions worldwide.
What are the underlying business or industry changes driving this perspective?
  • Elkem's strategic review of the Silicones division and operational improvements, especially in China, are expected to enhance competitiveness and potentially increase earnings once the review is completed by year-end.
  • The diverse geographical presence helps offset negative impacts from global trade tensions, suggesting that Elkem could maintain or increase revenue by leveraging its regional business model.
  • Initiatives to supply the green transition, such as R&D in carbon capture, storage, and using biogenic materials, could enhance long-term revenue and net margins by meeting rising demand for sustainable products.
  • Increased demand from sectors like automotive (driven by EV growth) and defense infrastructure projects (notably in Europe) may lead to higher sales volumes for Elkem's materials, positively impacting revenue.
  • The focus on cost efficiency and operational discipline, such as completing maintenance during periods of low demand, should help maintain strong margins and improve profitability when market conditions improve.

Elkem Earnings and Revenue Growth

Elkem Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Elkem's revenue will grow by 36.6% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 4.1% today to 4.5% in 3 years time.
  • Analysts expect earnings to reach NOK 2.0 billion (and earnings per share of NOK 2.44) by about September 2028, up from NOK 700.0 million today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 10.8x on those 2028 earnings, down from 22.4x today. This future PE is lower than the current PE for the NO Chemicals industry at 22.4x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.01%, as per the Simply Wall St company report.

Elkem Future Earnings Per Share Growth

Elkem Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Global trade tensions and proposed tariffs are creating uncertainty, which could negatively impact trade flows and market demand, affecting Elkem's future revenues and margins.
  • Weak market conditions and lower demand, particularly in China and the EU, are exerting downward pressure on prices for silicon and ferrosilicon, potentially reducing Elkem’s revenue and EBITDA margins.
  • The Silicon Products division experienced reduced sales volumes and a drop in operating income, impacted by maintenance stops and power curtailment, which could further affect profitability if such disruptions continue.
  • Declines in the global auto industry's consumer confidence and revised GDP forecasts signal economic slowdown, which might impact Elkem's critical markets like automotive and construction, thereby affecting future earnings.
  • Strategic review and potential sale of the Silicones division, coupled with trade tensions, could hamper negotiations and result in unclear future income streams from this segment, impacting Elkem’s net margins and revenue stability.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of NOK26.4 for Elkem based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of NOK30.0, and the most bearish reporting a price target of just NOK22.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be NOK43.2 billion, earnings will come to NOK2.0 billion, and it would be trading on a PE ratio of 10.8x, assuming you use a discount rate of 8.0%.
  • Given the current share price of NOK24.7, the analyst price target of NOK26.4 is 6.4% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives